Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia

Minimal (or measurable) residual (MRD) disease provides a biomarker of response quality for which there is robust validation in the context of modern intensive treatment for younger patients with Acute Myeloid Leukemia (AML). Nevertheless, it remains a relatively unexplored area in older patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Buccisano, Francesco, Dillon, Richard, Freeman, Sylvie D., Venditti, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070940/
https://www.ncbi.nlm.nih.gov/pubmed/29949858
http://dx.doi.org/10.3390/cancers10070215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070940/
https://www.ncbi.nlm.nih.gov/pubmed/29949858
http://dx.doi.org/10.3390/cancers10070215

Ejemplares similares